Zu "152121-30-7" wurden 4 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
SB 202190
Artikelnummer: Cay10010399-10
SB 202190 is a selective, potent, cell-permeable inhibitor of p38 MAP kinases, inhibiting p38alpha (SAPK2A, MAPK14) and p38beta (SAPK2B, MAPK11) with IC50 values of 50 and 100 nM, respectively. When tested at 10 µM, SB 202190 has negligible effects on a range of other kinases, including other MAP kinases (ERKs,...
| Schlagworte: | 4-[4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-phenol |
| Anwendung: | MAP kinases Inhibitor |
| CAS | 152121-30-7 |
| MW: | 331.3 D |
ab 40,00 €
SB202190
Artikelnummer: AG-CR1-0028-M001
Potent and cell permeable p38 MAP kinase inhibitor, Apoptosis inducer, Inhibits p38alpha and beta, but not gamma and delta isoforms, Does not inhibit ERK2 or other members of the MAP kinase family or their upstream activators, JNK activator.
| Schlagworte: | FHPI, 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole |
| Anwendung: | p38 MAP kinase inhibitor |
| CAS | 152121-30-7 |
| MW: | 331,3 D |
ab 33,00 €
SAPK2, p38 MAPK Inhibitor (SB 202190) (Stress-activated...
Artikelnummer: S0096-25.1
SB 202190 is a cell permeable pyridinyl imidazole, which acts as a strong inhibitor of SAPK2a/p38 and SAPK2b/p38beta MAP kinases (IC50=280nM and 350nM, respectively). SB 202190 has no effect on the activity of the Erk or SAPK/JNK MAP kinases and is reported to block LPS induced TNF-a and IL-1beta production in mice....
| CAS | 152121-30-7 |
| MW: | 331.30 D |
814,00 €
SB-202190
Artikelnummer: LKT-S041001.5
| Schlagworte: | SB202190, SB 202190, FHPI, UNII-PVX798P8GI , 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole,... |
| Anwendung: | MAP kinases Inhibitor |
| CAS | 152121-30-7 |
| MW: | 331.35 D |
ab 95,00 €
